TXA administered intravenously, by injection reduces blood loss after knee replacement

Administering tranexamic acid (TXA) both intravenously (IV) and injected at the surgical site (intra-articular administration, or IA) reduced blood loss by 37 percent, compared to IV alone, following total knee replacement (TKR).

from Diet and Weight Loss News -- ScienceDaily http://bit.ly/25dWshI
Read BellyTrim XP Review: http://bit.ly/1DHzVpt